Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Delayed Toronto S.E.
Other stock markets
 15:57:51 23/05/2024 BST 		5-day change 1st Jan Change
0.475 CAD +1.06% Intraday chart for Satellos Bioscience Inc. -1.04% +10.47%
05-14 Satellos Bioscience Q1 Loss Widens Due To Higher Expenses; But Says "On track" to initiate Phase 1 First-in-human Clinical Trials Mid-2024 MT
03-27 Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SATELLOS BIOSCIENCE INC.
Bio Therapeutic Drugs
+1.06%-1.04%+10.47%-24.60% - 38.77M
Neutral
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Charts Satellos Bioscience Inc.
  5. Comparison Chart